Immunotherapy-linked Hypoparathyroidism Shows Need to Monitor Calcium

Immunotherapy-linked Hypoparathyroidism Shows Need to Monitor Calcium

284347

Immunotherapy-linked Hypoparathyroidism Shows Need to Monitor Calcium

The case of a 71-year-old man with hypoparathyroidism and low calcium that was induced by the cancer immunotherapy Keytruda (pembrolizumab) was described in a recent study. This is the third reported instance of Keytruda-induced hypoparathyroidism, highlighting the need for close monitoring of calcium and parathyroid hormone (PTH) levels in patients receiving the treatment, investigators said. The case report, “Pembrolizumab Associated Hypoparathyroidism: A Single Case Report,” was published in the journal AACE Clinical Case Reports. Hypoparathyroidism…

You must be logged in to read/download the full post.